Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/1998
11/05/1998WO1998048822A1 Improved methods for processing activated protein c
11/05/1998WO1998048818A1 Activated protein c formulations
11/05/1998WO1998048815A1 Use of zinc hyaluronate against peptic ulcer
11/05/1998WO1998048783A1 Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream
11/05/1998WO1998048781A1 Controlled release of drugs delivered by sublingual or buccal administration
11/05/1998WO1998048768A1 Compositions for cosmetic applications
11/05/1998WO1998043618A3 Use of cytoskeletal inhibitors for the prevention of restenosis
11/05/1998WO1998042312A3 Medicament having sclerosing activity
11/05/1998WO1998034596A3 Biocompatible compounds for pharmaceutical drug delivery systems
11/05/1998CA2614617A1 Pourable alginate compositions
11/05/1998CA2288138A1 Compounds and compositions for delivering active agents
11/05/1998CA2288014A1 Biodegradable compositions comprising poly(cycloaliphatic phosphoester) compounds, articles, and methods for using the same
11/05/1998CA2287976A1 Anti-helicobacter vaccine composition comprising a th1 adjuvant
11/05/1998CA2259464A1 Compositions for cosmetic applications
11/04/1998EP0875563A2 Improved methods for processing activated protein C
11/04/1998EP0875253A2 Chondroitinase compositions
11/04/1998EP0875252A2 Activated protein C formulations
11/04/1998EP0875244A2 Cosmetically accceptable microstructured compositions
11/04/1998EP0874821A1 Tetramethylpiperidine-containing copolymers
11/04/1998EP0874643A2 Bioresponsive pharmacologically-active polymers and articles made therefrom
11/04/1998EP0874642A1 Sustained release drug formulations
11/04/1998EP0874640A1 Cyclosporin formulation
11/04/1998EP0874632A1 High-content famciclovir tablets
11/04/1998EP0874624A2 Hyaluronic acid receptors binding agents and the use thereof
11/04/1998EP0874623A2 Water activatable adhesive matrix containing amethocaine
11/04/1998EP0874621A1 Pharmaceutical compositions
11/04/1998EP0874619A1 Compositions for treating hair or skin
11/04/1998EP0874558A1 Liquid oral compositions comprising a calcium compound and an acidulant
11/04/1998EP0710104B1 Pharmaceutical compositions for hardly soluble active substances
11/04/1998EP0696270B1 4-amino-fluorobenzamides and their use as cytotoxic prodrugs
11/04/1998EP0656950B1 Tat-derived transport polypeptides
11/04/1998EP0619802B1 A mixture of higher primary aliphatic alcohols and its pharmaceutical uses
11/04/1998EP0602144B1 Dna sequences encoding gelonin polypeptide
11/04/1998EP0552227B2 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation
11/04/1998CN1198183A Process for purifying alkoxylated fats
11/04/1998CN1198101A Compositions and their uses
11/04/1998CN1198100A Chitosan drug delivery system
11/04/1998CN1198097A Stable extract of hypericum perforatum L., process for preparing the same and pharmaceutical compositions
11/04/1998CN1198094A Solid medicaments obtained by extrusion of isomalt-containing polymer-active substance melt
11/04/1998CN1197639A Rapamycin formulations for oral administration
11/04/1998CN1040540C Anthracene ring antibiotic thioether conjugates, its prepn. and pharmaceutical composition containing same
11/03/1998US5831034 Human monoclonal anti-HIV-I-antibodies
11/03/1998US5830986 Polyethylene oxides
11/03/1998US5830948 Polymerizable macromonomers and polymers prepared therefrom
11/03/1998US5830884 Pharmaceutical products containing thermally-inhibited starches
11/03/1998US5830882 Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition
11/03/1998US5830880 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
11/03/1998US5830878 1,2-bis(2-oleoyloxy)ethyl)-3-(2-hydroxyethyl)imidazolinium chloride
11/03/1998US5830853 Administering insulin and absorption enhancer using a dry powder inhaler
11/03/1998US5830852 Compositions for insulin-receptor mediated nucleic acid delivery
11/03/1998US5830747 Plant arabinogalactan protein (AGP) genes
11/03/1998US5830506 Polysaccharide and natural macromolecule such as concanavalin a
11/03/1998US5830505 Active ingredient patch
11/03/1998US5830504 Cooperative combinations of ligands contained within a matrix
11/03/1998US5830502 Solvent-free housing
11/03/1998US5830492 Matrix containing a hormone encapsulated with polymer
11/03/1998US5830473 Antibodies against T cells as therapeutics
11/03/1998US5830463 Yeast-based delivery vehicles
11/03/1998US5830462 Regulated transcription of targeted genes and other biological events
11/03/1998US5830436 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
11/03/1998US5830432 Phospholipid drug derivatives
11/03/1998US5830430 Cationic lipids and the use thereof
11/03/1998US5830178 Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide
11/03/1998CA2181929C Compositions for treatment of glaucoma comprising pilocarpine and a beta-blocker
11/03/1998CA2119253C Medication vehicles made of solid lipid particles (solid lipid nanospheres-sln)
11/03/1998CA2067807C Alcoholic aqueous gel-type phospholipid composition, its use and topical preparations containing it
10/1998
10/29/1998WO1998047915A1 Neoglycoproteins
10/29/1998WO1998047865A1 Amphiphilic compounds with at least two hydrophilic and at least two hydrophobic groups on a di- oligo- or polyene base
10/29/1998WO1998047610A1 Composition based on alkylpolyglycosides and fatty alcohols, and uses thereof
10/29/1998WO1998047541A1 Contrast agents
10/29/1998WO1998047537A1 Polymer-platinum compounds
10/29/1998WO1998047536A1 Controlled release of ophthalmic compositions
10/29/1998WO1998047535A1 Improved delivery of drugs to mucosal surfaces
10/29/1998WO1998047534A1 Stabilized medicaments containing cysteinyl derivatives
10/29/1998WO1998047530A2 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines
10/29/1998WO1998047519A1 Methods and compositions for the prevention and treatment of muscle cramps and improving muscular strength in athletes
10/29/1998WO1998047517A1 Stabilized tibolone compositions
10/29/1998WO1998047512A1 1,2,4-benzotriazine oxides formulations
10/29/1998WO1998047506A1 Gastric-retained pharmaceutical composition
10/29/1998WO1998047501A1 Pharmaceutical preparation containing nimesulide for oral administration
10/29/1998WO1998047496A2 Polymer-platinum compounds
10/29/1998WO1998047490A1 Stable pharmaceutical administration forms of peptides, proteins and nucleic acids
10/29/1998WO1998047489A1 Sustained-release compositions and method for preparing same
10/29/1998WO1998047483A1 Confectionery compositions
10/29/1998WO1998047482A1 Throat soothing compositions
10/29/1998WO1998047468A1 Aqueous compositions comprising a lipid and a lanolin-derived surfactant, and their use
10/29/1998WO1998047374A1 Topical use of probiotic bacillus spores to prevent or control microbial infections
10/29/1998WO1998033470A3 Substituted perylenequinones for use in photodynamic therapy
10/29/1998WO1998020964A3 Novel fatty alcohol sulfates and alkylethersulfates with trialkylammonium counter-ions and well as their production and use
10/29/1998DE19717968A1 Verfahren zur Herstellung von Kohlenhydratpartialestern A process for the production of carbohydrate
10/29/1998DE19717264A1 Amphiphole Verbindungen mit mindestens zwei hydrophilen und mindestens zwei hydrophoben Gruppen auf der Basis von Di, Oligo- oder Polyenen Amphiphole compounds having at least two hydrophilic and at least two hydrophobic groups based on di-, oligo- or polyenes
10/29/1998CA2288649A1 Stable pharmaceutical administration forms of peptides, proteins and nucleic acids
10/29/1998CA2288267A1 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines
10/29/1998CA2288070A1 Stabilized tibolone compositions
10/29/1998CA2287451A1 Topical use of probiotic bacillus spores to prevent or control microbial infections
10/29/1998CA2286081A1 Gastric-retained pharmaceutical composition
10/29/1998CA2284729A1 Neoglycoproteins
10/29/1998CA2236131A1 Emulsion preconcentrate comprising a cyclosporin propylene carbonate and glycerides
10/28/1998EP0874000A2 Natural substituted powdered polymers, a process for production and their applications
10/28/1998EP0873751A2 Pharmaceutical product for application to uterus mucosa
1 ... 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 ... 1712